Hunan Jiudian Pharmaceutical Co Ltd (300705) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hunan Jiudian Pharmaceutical Co Ltd (300705) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥180.33 Million ≈ $26.39 Million USD) by net assets (CN¥2.66 Billion ≈ $388.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hunan Jiudian Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Hunan Jiudian Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Hunan Jiudian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hunan Jiudian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Jiudian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 300705 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Changzhou Galaxy Century Microelectronics Co Ltd
SHG:688689
|
0.006x |
|
Jiangsu Boiln Plastics Co. Ltd.
SHE:301003
|
0.028x |
|
Guangdong Hotata Technology Group Co Ltd Class A
SHG:603848
|
0.029x |
|
Vercom SA
WAR:VRC
|
0.066x |
|
Peakstone Realty Trust
NYSE:PKST
|
0.037x |
|
Elsight Ltd
AU:ELS
|
0.272x |
|
Greenfire Resources Ltd.
NYSE:GFR
|
0.031x |
|
Metals X Limited
F:FG5
|
0.028x |
Annual Cash Flow Conversion Efficiency for Hunan Jiudian Pharmaceutical Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2025. View Hunan Jiudian Pharmaceutical Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.79 Billion ≈ $407.71 Million |
CN¥647.06 Million ≈ $94.68 Million |
0.232x | -21.38% |
| 2024-12-31 | CN¥2.53 Billion ≈ $369.74 Million |
CN¥746.36 Million ≈ $109.22 Million |
0.295x | +35.18% |
| 2023-12-31 | CN¥1.97 Billion ≈ $288.75 Million |
CN¥431.19 Million ≈ $63.10 Million |
0.219x | +26.13% |
| 2022-12-31 | CN¥1.55 Billion ≈ $227.20 Million |
CN¥268.99 Million ≈ $39.36 Million |
0.173x | -0.22% |
| 2021-12-31 | CN¥1.10 Billion ≈ $160.87 Million |
CN¥190.87 Million ≈ $27.93 Million |
0.174x | -3.27% |
| 2020-12-31 | CN¥835.68 Million ≈ $122.29 Million |
CN¥149.99 Million ≈ $21.95 Million |
0.179x | +50.70% |
| 2019-12-31 | CN¥761.87 Million ≈ $111.49 Million |
CN¥90.74 Million ≈ $13.28 Million |
0.119x | +25.36% |
| 2018-12-31 | CN¥718.16 Million ≈ $105.09 Million |
CN¥68.23 Million ≈ $9.98 Million |
0.095x | -21.99% |
| 2017-12-31 | CN¥660.26 Million ≈ $96.62 Million |
CN¥80.42 Million ≈ $11.77 Million |
0.122x | -28.61% |
| 2016-12-31 | CN¥323.43 Million ≈ $47.33 Million |
CN¥55.18 Million ≈ $8.07 Million |
0.171x | +34.88% |
| 2015-12-31 | CN¥254.51 Million ≈ $37.24 Million |
CN¥32.20 Million ≈ $4.71 Million |
0.126x | -11.82% |
| 2014-12-31 | CN¥209.87 Million ≈ $30.71 Million |
CN¥30.11 Million ≈ $4.41 Million |
0.143x | -17.81% |
| 2013-12-31 | CN¥175.85 Million ≈ $25.73 Million |
CN¥30.69 Million ≈ $4.49 Million |
0.175x | -- |
About Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches,… Read more